Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
12 hedge funds and large institutions have $5.04M invested in Biocept, Inc. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
46% more capital invested
Capital invested by funds: $3.46M → $5.04M (+$1.58M)
1.94% more ownership
Funds ownership: 8.62% → 10.57% (+1.9%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $29K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.69M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$154K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$154K |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$154K |
| 5 |
Morgan Stanley
New York
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$492K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$154K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$69K |
| 4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$68K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$40K |
BIOC Hedge Fund Activity: Q2 2015 in Review
12 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2015, worth a combined $5.04M — up 46% from $3.46M a quarter earlier.
Fund positioning in BIOC was balanced in Q2 2015: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Archon Capital Management, opening a new position worth an estimated $1.69M. The largest seller was Spark Investment Management, exiting entirely with an estimated $492K sold.
- 12 institutional investors held Biocept, Inc. (BIOC) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $5.04M of Biocept, Inc. stock for Q2 2015, up 46% quarter-over-quarter.
- 4 funds opened new Biocept, Inc. positions in Q2 2015 and 4 closed out, a net change of 0 holders.
- The largest Biocept, Inc. buyer in Q2 2015 was Archon Capital Management, an estimated $1.69M added.
- The largest Biocept, Inc. seller in Q2 2015 was Spark Investment Management, an estimated $492K sold.
Based on aggregated 13F filings for Q2 2015.